机构地区:[1]浙江省绍兴市人民医院血液科,绍兴市医学研究中心,绍兴312000
出 处:《华中科技大学学报(医学版)》2013年第4期476-479,共4页Acta Medicinae Universitatis Scientiae et Technologiae Huazhong
基 金:浙江省绍兴市科技局一般项目(No.2009A33030)
摘 要:目的研究成人慢性特发性中性粒细胞减少症(ACIN)患者与幽门螺杆菌(Hp)感染的关系,并探讨ACIN患者的Hp感染与脾肿大、血清炎症因子、超敏C反应蛋白(hsCRP)的关系。方法选取88例ACIN患者(ACIN组),40名健康体检者(对照组),采用14 C呼气试验检测Hp感染,B超检测并计算矫正脾指数(CSI),双抗体夹心ELISA法测定血清IL-6、IL-8、IL-10,颗粒增强免疫沉淀法测定血清hsCRP。ACIN组Hp阴性患者单以利可君治疗,Hp阳性患者联用利可君和三联抗Hp治疗(奥美拉唑+克拉霉素+阿莫西林)。结果①ACIN组Hp感染率60.23%,明显高于对照组35.00%(P<0.05)。②ACIN组Hp阳性患者抗Hp联合治疗后,抗粒细胞减少治疗总有效率77.36%,1年随访复发率20.69%,与Hp阴性患者51.43%、75.00%比较差异有统计学意义(均P<0.05)。③ACIN组及对照组Hp阳性患者CSI值明显高于同组内阴性患者;随访满1年的38例Hp阳性ACIN组未复发患者CSI值较其治疗前明显下降(P<0.05)。④ACIN组及对照组Hp阳性患者血清IL-6、IL-8、IL-10、hsCRP水平均明显高于同组内阴性患者(均P<0.05);ACIN组Hp阳性患者IL-6明显高于对照组Hp阳性患者,IL-10则明显下降(均P<0.05);ACIN组Hp阴性患者IL-6、IL-8、IL-10、hsCRP与对照组Hp阴性患者差异无统计学意义。随访满1年的38例Hp阳性ACIN组未复发患者IL-6、IL-10恢复至Hp阴性对照组水平。⑤ACIN组中性粒细胞计数与IL-6水平呈显著负相关,与IL-10水平呈显著正相关。结论 Hp感染可能是部分ACIN的病因,抗Hp联合治疗疗效好。Hp感染可能通过脾肿大及血清IL-6、IL-10变化诱发ACIN。Objective To study the correlation of Helicobacter pylori(Hp) infection with splenomegaly,the levels of serum inflammatory factors and high-sensitivity c-reactive protein(hsCRP) in patients with adult chronic idiopathic neufropenia(ACIN) patients in an attempt to explore the clinical association of ACIN with Hp infection.Methods A total of 88ACIN patients(ACIN group) and 40normal subjects(control group) were enrolled.14 C breath test was used to determine the Hp infection.Corrected splenic index(CSI) was calculated by using B-mode ultrasonography,the levels of serum interleukins(IL-6,IL8,and IL-10) by double-antibody sandwich ELISA and the serum hsCRP level by immunolurbidimelric assay.In the ACIN group,Hp-negative patients were treated with leucoson and Hp-positive patients with leucoson and three-drug combination treatment(omeprazole+clarithromycin+amoxycillin).Results ①Hp incidence in ACIN group was 60.23%,significantly higher than in control group(P〈0.05).②The total effective rate for neutropenia was 77.36%,and 1-year recurrence rate was 20.69%in Hp-positive patients,which were significantly different from those in Hp-negative patients(total effective rate : 51.43%,1-year recurrence rate : 75.00%)(P〈0.05).③The CSI was significantly higher in Hp-positive subjects than in the Hp-negative subjects in both ACIN and control groups.Among the 38Hp-positive patients in ACIN group through one-year follow-up,the CSI in patients without recurrence was significantly decreased compared with those before treatment(P〈0.05).④The levels of serum IL-6,IL-8,IL-10,and hsCRP were much higher in Hp-positive subjects than in Hp-negative ones in both ACIN and control groups(P〈0.05).The level of serum IL-6was substantially enhanced and the serum IL-10 level decreased in Hp-positive patients in ACIN group when compared with those in control group(P〈0.05).There were no significant differences in the levels of serum IL-6,IL-8,IL-10,and hsCRP between the AC
分 类 号:R557[医药卫生—血液循环系统疾病]
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...